ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 18.60 Delayed Data As of Mar 27 |  +0.36 / +1.97%Today’s Change | 12.24 Today|||52-Week Range 28.06 | +16.83% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 61.0K | 17.3M | 124.9M | 223.8M | |
| Cost of Goods Sold | -- | 1.2M | 6.4M | 9.4M | ||
| Depreciation And Amortization | 647.0K | 1.8M | 2.7M | 3.0M | ||
| Operating Expenses | Gross Income | -- | 14.3M | 115.8M | 211.4M | |
| General Expenses | 161.5M | 285.7M | 404.3M | 458.9M | ||
| Other Operating Expenses | 2.5M | 1.3M | 4.0M | 0.00 | ||
| Research And Development | 73.9M | 99.3M | 149.2M | 187.2M | ||
| Total Operating Expenses | 164.7M | 290.1M | 417.3M | 471.3M | ||
| Non-Operating Expenses | Operating Income | -164.6M | -272.8M | -292.4M | -247.4M | |
| Other Expenses | 0.00 | 0.00 | 0.00 | -1.8M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -164.1M | -270.1M | -288.3M | -243.9M | |
| Income Taxes | -330.0K | -1.3M | -1.1M | -1.3M | ||
| Net Income | -164.4M | -271.4M | -289.4M | -245.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 100.6M | 115.9M | 122.6M | 126.6M | |
| Shares To Calculate EPS Diluted | 100.6M | 115.9M | 122.6M | 126.6M | ||
| Earnings Per Share | EPS | -$1.63 | -$2.34 | -$2.36 | -$1.94 | |
| EPS Diluted | -$1.63 | -$2.34 | -$2.36 | -$1.94 | ||
